Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Davidson M, Aronson LI, Howard-Reeves J, Bryant H, Cutts RJ, Hulkki-Wilson S, Kouvelakis K, Kalaitzaki E, Watkins D, Starling N, Rao S, Cardenosa ML, Begum R, Rana I, Lazaro-Alcausi R, Terlizzo M, Wotherspoon A, Brown G, Swansbury J, Lord CJ, Cunningham D, Chau I, Chong IY. Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme. Eur J Cancer 2019;122:12-21. [PMID: 31606655 DOI: 10.1016/j.ejca.2019.09.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 08/19/2019] [Accepted: 09/03/2019] [Indexed: 12/11/2022]

For:	Davidson M, Aronson LI, Howard-Reeves J, Bryant H, Cutts RJ, Hulkki-Wilson S, Kouvelakis K, Kalaitzaki E, Watkins D, Starling N, Rao S, Cardenosa ML, Begum R, Rana I, Lazaro-Alcausi R, Terlizzo M, Wotherspoon A, Brown G, Swansbury J, Lord CJ, Cunningham D, Chau I, Chong IY. Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme. Eur J Cancer 2019;122:12-21. [PMID: 31606655 DOI: 10.1016/j.ejca.2019.09.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 08/19/2019] [Accepted: 09/03/2019] [Indexed: 12/11/2022]

Number

Cited by Other Article(s)

Chong IY, Chau I. Is there still a place for radiotherapy in gastric cancer? Curr Opin Pharmacol 2023;68:102325. [PMID: 36610101 DOI: 10.1016/j.coph.2022.102325] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Revised: 10/31/2022] [Accepted: 11/01/2022] [Indexed: 01/07/2023]

Turkes F, Bryant A, Begum R, Davidson M, Kalaitzaki E, Aresu M, Lazaro-Alcausi R, Bryant J, Rana I, Chua S, Aronson L, Hulkki-Wilson S, Fribbens C, Watkins D, Rao S, Starling N, Cunningham D, Chong IY, Chau I. Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study. Curr Oncol 2022;29:2174-2184. [PMID: 35448150 PMCID: PMC9029374 DOI: 10.3390/curroncol29040176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Revised: 03/02/2022] [Accepted: 03/14/2022] [Indexed: 11/24/2022] Open

Affiliation(s)

Fiona Turkes Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Annette Bryant Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Ruwaida Begum Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Michael Davidson Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Eleftheria Kalaitzaki Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Maria Aresu Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Retchel Lazaro-Alcausi Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Jane Bryant Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Isma Rana Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Sue Chua Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Lauren Aronson Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; (L.A.); (I.Y.C.)
Sanna Hulkki-Wilson Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Charlotte Fribbens Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
David Watkins Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Sheela Rao Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Naureen Starling Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
David Cunningham Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.)
Irene Y. Chong Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; (L.A.); (I.Y.C.)
Ian Chau Royal Marsden NHS Foundation Trust, Downs Road, Surrey SM2 5PT, UK; (F.T.); (A.B.); (R.B.); (M.D.); (E.K.); (M.A.); (R.L.-A.); (J.B.); (I.R.); (S.C.); (S.H.-W.); (C.F.); (D.W.); (S.R.); (N.S.); (D.C.) Correspondence:

Collapse